INmune Bio, Inc. Awarded $500,000 Grant for Development of Novel Treatment to Reprogram Innate Immune System in People Living with ALS
Grant will fund proof-of-concept studies for XPro1595 therapyLA JOLLA, Calif. , Feb. 10, 2020 (GLOBE NEWSWIRE) — INmune Bio, Inc. […]